Overview

Netholabs develops AI-native models that simulate biology and behavior to create “digital organisms.” It builds large, multi-modal datasets from preclinical CNS research and trains probabilistic, counterfactual AI models that can reason about biology and behavior. The goal is to enable rapid in silico experiments—ranking targets, simulating interventions, and prioritizing research programs—so pharmaceutical companies and research partners can accelerate target discovery and preclinical decision-making for neural disorders. The models start with mice and aim toward humans, functioning as neuro-behavioral foundation models. The company partners with pharma, academia, and technology players, and also integrates with other AI/data platforms while pursuing AI safety research by using whole-brain emulation to study goal formation and alignment in AI systems.